53 related articles for article (PubMed ID: 7890226)
1. Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis.
Li B; Flaveny CA; Giambelli C; Fei DL; Han L; Hang BI; Bai F; Pei XH; Nose V; Burlingame O; Capobianco AJ; Orton D; Lee E; Robbins DJ
PLoS One; 2014; 9(7):e101969. PubMed ID: 25003333
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of oesophageal cancer and the AspECT trial.
Das D; Chilton AP; Jankowski JA
Recent Results Cancer Res; 2009; 181():161-9. PubMed ID: 19213566
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.
Wang F; Lv ZS; Fu YK
Dis Esophagus; 2011 Jul; 24(5):318-24. PubMed ID: 21166737
[TBL] [Abstract][Full Text] [Related]
4. NSAIDs and the chemoprevention of colon and oesophageal cancer.
Morgan GP
Gut; 1995 Jan; 36(1):153-4. PubMed ID: 7890226
[No Abstract] [Full Text] [Related]
5. NSAID chemoprevention of colorectal adenomas and oesophageal metaplasia.
Morgan G
J R Soc Med; 1996 Apr; 89(4):237. PubMed ID: 8676327
[No Abstract] [Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs and the chemoprevention of colorectal and oesophageal cancers.
Morgan G
Gut; 1996 May; 38(5):646-8. PubMed ID: 8707106
[No Abstract] [Full Text] [Related]
7. Aspirin: the balance between benefits and harms. Preface.
Lanas A
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):97-9. PubMed ID: 22542148
[No Abstract] [Full Text] [Related]
8. Aspirin, NSAIDS and human cancer.
Hill MJ
Eur J Cancer Prev; 1996 Aug; 5(4):219-20. PubMed ID: 8894558
[No Abstract] [Full Text] [Related]
9. NSAIDS and esophageal cancer.
Scherübl H; Sutter AP; Zeitz M
Gastroenterology; 2003 Dec; 125(6):1914-5; author reply 1915. PubMed ID: 14727630
[No Abstract] [Full Text] [Related]
10. Aspirin and risk of fatal colon cancer.
Odeh M
Postgrad Med J; 1993 Mar; 69(809):242. PubMed ID: 8497448
[No Abstract] [Full Text] [Related]
11. Prevalence survey of precancerous lesions of the oesophagus in a high-risk population for oesophageal cancer in France.
Jacob JH; Riviere A; Mandard AM; Muñoz N; Crespi M; Etienne Y; Castellsagué X; Marnay J; Lebigot G; Qiu SL
Eur J Cancer Prev; 1993 Jan; 2(1):53-9. PubMed ID: 8428178
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and risk of fatal colon cancer.
Morgan GP; Williams JG
Postgrad Med J; 1993 Nov; 69(817):893-4. PubMed ID: 8290442
[No Abstract] [Full Text] [Related]
13. Therapeutic potential of aspirin in cancer of the colon.
Morgan GP; Williams JG
BMJ; 1993 Oct; 307(6910):1007-8. PubMed ID: 8204142
[No Abstract] [Full Text] [Related]
14. NSAIDs and the chemoprevention of oesophageal cancer.
Morgan GP; Williams JG
Lancet; 1994 Jan; 343(8890):176-7. PubMed ID: 7904024
[No Abstract] [Full Text] [Related]
15. Immunosuppression in patients with Barrett's esophagus.
Oka M; Attwood SE; Kaul B; Smyrk TC; DeMeester TR
Surgery; 1992 Jul; 112(1):11-7. PubMed ID: 1621218
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
